Retrogenix discusses specificity screening at CAR-TCR conference
Dr Jim Freeth will present strategies for specificity screening of cell therapies using human cell microarray technology at the CAR-TCR Summit Europe held this week in London, UK.
The event focuses on the delivery of safe and effective next generation CAR or TCR driven cell immunotherapies to patients.
We will also be exhibiting and welcome discussions with delegates throughout the event!
For further details on our CAR-T screening capabilities see here.